Drug Type Small molecule drug |
Synonyms Enalapril Maleate and Hydrochlorothiazide, 马来酸依那普利/氢氯噻嗪, Vaseretic + [2] |
Target |
Action inhibitors |
Mechanism ACE inhibitors(Angiotensin-converting enzyme inhibitors), NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (31 Oct 1986), |
Regulation- |
Molecular FormulaC24H32N2O9 |
InChIKeyOYFJQPXVCSSHAI-QFPUQLAESA-N |
CAS Registry76095-16-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | United States | 31 Oct 1986 |